[Skip to Navigation]
Sign In
Comment & Response
October 6, 2021

New Insights on the Treatment of Colorectal Peritoneal Metastases From the CAIRO6 Trial

Author Affiliations
  • 1Department of Surgical Oncology, Zydus Hospital, Ahmedabad, India
  • 2Department of Surgical Oncology, Centre Hospitalier Lyon-sud, Lyon, France
JAMA Surg. 2022;157(2):171. doi:10.1001/jamasurg.2021.5024

To the Editor We read with interest the results of phase 2 of the CAIRO6 trial that showed the feasibility and safety of perioperative chemotherapy in patients with resectable colorectal peritoneal metastases (CPM).1 The major postoperative morbidity was similar in both arms, although the absolute figures showed a lower morbidity in the experimental arm (22% vs 33% in the control arm).

Add or change institution